Damora Therapeutics (DMRA) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,688.85% |
| Dec 31, 2025 | 122.08% |
| Sep 30, 2025 | -13.04% |
| Jun 30, 2025 | 4.17% |
| Mar 31, 2025 | 51.15% |
| Dec 31, 2024 | -33.25% |
| Sep 30, 2024 | 10.07% |
| Jun 30, 2024 | 30.51% |
| Mar 31, 2024 | 48.53% |
| Dec 31, 2023 | -35.59% |
| Sep 30, 2023 | -7.24% |
| Jun 30, 2023 | 13.37% |
| Mar 31, 2023 | 20.51% |
| Dec 31, 2022 | -16.26% |
| Sep 30, 2022 | 33.65% |
| Jun 30, 2022 | -118.33% |
| Mar 31, 2022 | 61.88% |
| Dec 31, 2021 | -94.66% |
| Sep 30, 2021 | 18.00% |
| Jun 30, 2021 | 21.07% |
| Mar 31, 2021 | 2.52% |
| Dec 31, 2020 | -69.25% |
| Sep 30, 2020 | -20.28% |
| Jun 30, 2020 | 10.62% |
| Mar 31, 2020 | -51.88% |